Patents by Inventor Jesse Wheeler

Jesse Wheeler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260115468
    Abstract: An auricular stimulation device having surface electrodes biased towards each other, and offset from one another, is provided. The stimulation device can be positioned about the ear of a patient with each of the electrodes overlaying auricular ear tissue containing innervation supplied by an auricular branch of the vagus nerve. The electrodes transcutaneously stimulate the auricular branch. Also provided is a method of treating a patient using the auricular stimulation device. The stimulation device can be used for treating patients with conditions such as high blood pressure, depression, high blood glucose level, and tinnitus. Also provided is a diagnostic and therapeutic system having the auricular stimulation device, a smart device and a monitoring device. The smart device controls the auricular stimulation device based on biomarker information received from the monitoring device; and on information related to the patient, such as age, musculoskeletal stability, etc.; and/or on user input.
    Type: Application
    Filed: October 10, 2025
    Publication date: April 30, 2026
    Applicant: Aurenar, Inc.
    Inventors: Jesse Wheeler, Eric Leuthardt, Jenna Gorlewicz, Joe St Cyr, Jim Best, Chris Labak, Robert McCaffrey, Garrett Casey, Nick Vallo, Jay Goodell, Stanislav Polipas
  • Publication number: 20260115491
    Abstract: Methods for treating patients receiving a medication are disclosed. A patient is administered a medication with a propensity to cause inflammation or inflammation-related side effects, or actually experiences inflammation or inflammation-related side effects in response to receiving a medication. In response, vagus nerve stimulation is provided to the patient to relieve the inflammation or inflammation-related side-effect(s). The vagus nerve stimulation may be delivered by a transcutaneous system. Any of mechanical, optical, and/or electrical energy, pulses, power, etc. may be used to target the vagus nerve. Some examples deliver the stimulation to the auricular branch of the vagus nerve.
    Type: Application
    Filed: October 30, 2025
    Publication date: April 30, 2026
    Applicant: Aurenar, Inc.
    Inventors: Jesse Wheeler, Eric Leuthardt, Jenna Gorlewicz
  • Patent number: 12470859
    Abstract: An example wearable device for placement relative to an ear includes a housing; a first extending structure; a second extending structure, the first and second extending structures are separated by an adjustable distance; a carriage coupled to the second extending structure and being at least partially disposed within the housing, the carriage being configured to move longitudinally along the housing and an adjustment mechanism configured to impart a force to cause longitudinal movement of the carriage to adjust the adjustable distance.
    Type: Grant
    Filed: April 22, 2025
    Date of Patent: November 11, 2025
    Assignee: Aurenar, Inc.
    Inventors: Jesse Wheeler, Eric Leuthardt, Jenna Gorlewicz, Joe St Cyr, Jim Best, Chris Labak, Robert McCaffrey, Garrett Casey, Nick Vallo, Jay Goodell, Stan Polipas
  • Publication number: 20180249954
    Abstract: This invention provides a system and method for performing a surgical procedure that effectively locates and allows a user to avoid engagement with hidden nerves in tissue in real-time. The system and method employs an integrated stimulating and sensing array. The array includes a plurality of spaced-apart electrodes, which are selectively stimulated while the electrodes then sense for a neural response. Each of the electrodes is stimulated to map of the sensed tissue region for localization of nerve paths. This localization can be stored and used to control cutting of tissue. The locations can be marked as nerve-free and/or no-go regions so as to avoid nerve-containing regions in subsequent procedures or following a stimulation procedure. This marking can be by any acceptable physical and/or virtual fiducial mechanism. The array can be a single structure with all relevant electrodes or some electrodes can be provided in a separate, remote probe assembly.
    Type: Application
    Filed: March 1, 2018
    Publication date: September 6, 2018
    Inventors: Daniel K. Freeman, Andrew A. Berlin, Jesse Wheeler